134 related articles for article (PubMed ID: 29111215)
1. Methotrexate versus azathioprine in patients with atopic dermatitis: 2-year follow-up data.
Roekevisch E; Schram ME; Leeflang MMG; Brouwer MWD; Gerbens LAA; Bos JD; Spuls PI
J Allergy Clin Immunol; 2018 Feb; 141(2):825-827.e10. PubMed ID: 29111215
[No Abstract] [Full Text] [Related]
2. A randomized trial of methotrexate versus azathioprine for severe atopic eczema.
Schram ME; Roekevisch E; Leeflang MM; Bos JD; Schmitt J; Spuls PI
J Allergy Clin Immunol; 2011 Aug; 128(2):353-9. PubMed ID: 21514637
[TBL] [Abstract][Full Text] [Related]
3. Patients with atopic dermatitis with filaggrin loss-of-function mutations show good but lower responses to immunosuppressive treatment.
Roekevisch E; Leeflang MMG; Schram ME; Campbell LE; Irwin McLean WH; Kezic S; Bos JD; Spuls PI; Middelkamp-Hup MA
Br J Dermatol; 2017 Dec; 177(6):1745-1746. PubMed ID: 27864930
[No Abstract] [Full Text] [Related]
4. Methotrexate and azathioprine for severe atopic dermatitis: a 5-year follow-up study of a randomized controlled trial.
Gerbens LAA; Hamann SAS; Brouwer MWD; Roekevisch E; Leeflang MMG; Spuls PI
Br J Dermatol; 2018 Jun; 178(6):1288-1296. PubMed ID: 29237228
[TBL] [Abstract][Full Text] [Related]
5. Skin barrier function in atopic dermatitis.
Vickery BP
Curr Opin Pediatr; 2007 Feb; 19(1):89-93. PubMed ID: 17224668
[TBL] [Abstract][Full Text] [Related]
6. [BARRIER FUNCTION AND CUTANEOUS IMMUNOLOGY].
Otsuka A; Kabashima K
Arerugi; 2015 Sep; 64(9):1189-95. PubMed ID: 26657906
[No Abstract] [Full Text] [Related]
7. Association of Filaggrin loss-of-function-mutations with atopic dermatitis and asthma in the Early Treatment of the Atopic Child (ETAC) population.
Müller S; Marenholz I; Lee YA; Sengler C; Zitnik SE; Griffioen RW; Meglio P; Wahn U; Nickel R
Pediatr Allergy Immunol; 2009 Jun; 20(4):358-61. PubMed ID: 19538357
[TBL] [Abstract][Full Text] [Related]
8. Filaggrin null mutations in childhood atopic dermatitis among the Chinese.
Ching GK; Hon KL; Ng PC; Leung TF
Int J Immunogenet; 2009 Aug; 36(4):251-4. PubMed ID: 19602001
[TBL] [Abstract][Full Text] [Related]
9. Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany.
Schmitt J; Abraham S; Trautmann F; Stephan V; Fölster-Holst R; Homey B; Bieber T; Novak N; Sticherling M; Augustin M; Kleinheinz A; Elsner P; Weidinger S; Werfel T
J Dtsch Dermatol Ges; 2017 Jan; 15(1):49-59. PubMed ID: 27862987
[TBL] [Abstract][Full Text] [Related]
10. Our evolving understanding of the functional role of filaggrin in atopic dermatitis.
Leung DY
J Allergy Clin Immunol; 2009 Sep; 124(3):494-5. PubMed ID: 19733296
[No Abstract] [Full Text] [Related]
11. [Genetics of skin barrier impairment in atopic dermatitis].
Audigier V; Shisha A; Jullien D
Ann Dermatol Venereol; 2008 Jan; 135(1):34-7. PubMed ID: 18342071
[No Abstract] [Full Text] [Related]
12. Update on systemic therapies for atopic dermatitis.
Denby KS; Beck LA
Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):421-6. PubMed ID: 22622476
[TBL] [Abstract][Full Text] [Related]
13. Review of Critical Issues in the Pathogenesis of Atopic Dermatitis.
Irvine AD; Eichenfield LF; Friedlander SF; Simpson EL
Semin Cutan Med Surg; 2016 Jun; 35(5 Suppl):S89-91. PubMed ID: 27525507
[TBL] [Abstract][Full Text] [Related]
14. New insights in the pathogenesis of atopic dermatitis.
Ong PY
Pediatr Res; 2014 Jan; 75(1-2):171-5. PubMed ID: 24192701
[TBL] [Abstract][Full Text] [Related]
15. Atopic dermatitis, filaggrin mutations and irritant contact dermatitis.
Thyssen JP
Br J Dermatol; 2013 Feb; 168(2):233-4. PubMed ID: 23362965
[No Abstract] [Full Text] [Related]
16. Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults.
Hon KL; Ching GK; Leung TF; Chow CM; Lee KK; Ng PC
J Dermatolog Treat; 2009; 20(3):141-5. PubMed ID: 18951236
[TBL] [Abstract][Full Text] [Related]
17. The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring.
Fuggle NR; Bragoli W; Mahto A; Glover M; Martinez AE; Kinsler VA
J Am Acad Dermatol; 2015 Jan; 72(1):108-14. PubMed ID: 25440430
[TBL] [Abstract][Full Text] [Related]
18. IgE-independent pathophysiology of severe atopic dermatitis demonstrated in an IgE-deficient patient.
Ogawa Y; Kono M; Tsujikawa M; Tsujiuchi H; Akiyama M
J Dermatol Sci; 2016 May; 82(2):139-41. PubMed ID: 26846942
[No Abstract] [Full Text] [Related]
19. Retrospective review of the use of azathioprine in severe atopic dermatitis.
Lear JT; English JS; Jones P; Smith AG
J Am Acad Dermatol; 1996 Oct; 35(4):642-3. PubMed ID: 8859304
[No Abstract] [Full Text] [Related]
20. Combined occurrence of filaggrin mutations and IL-10 or IL-13 polymorphisms predisposes to atopic dermatitis.
Lesiak A; Kuna P; Zakrzewski M; van Geel M; Bladergroen RS; Przybylowska K; Stelmach I; Majak P; Hawro T; Sysa-Jedrzejowska A; Narbutt J
Exp Dermatol; 2011 Jun; 20(6):491-5. PubMed ID: 21426411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
